China Peptide Microarray Market Size & Outlook, 2022-2030

The peptide microarray market in China is expected to reach a projected revenue of US$ 22.0 million by 2030. A compound annual growth rate of 6.1% is expected of China peptide microarray market from 2023 to 2030.
Revenue, 2022 (US$M)
$13.7
Forecast, 2030 (US$M)
$22.0
CAGR, 2023 - 2030
6.1%
Report Coverage
China

China peptide microarray market highlights

  • The China peptide microarray market generated a revenue of USD 13.7 million in 2022 and is expected to reach USD 22.0 million by 2030.
  • The China market is expected to grow at a CAGR of 6.1% from 2023 to 2030.
  • In terms of segment, instruments was the largest revenue generating type in 2022.
  • Reagents is the most lucrative type segment registering the fastest growth during the forecast period.


Peptide microarray market data book summary

Market revenue in 2022USD 13.7 million
Market revenue in 2030USD 22.0 million
Growth rate6.1% (CAGR from 2022 to 2030)
Largest segmentInstruments
Fastest growing segmentReagents
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Reagents, Services
Key market players worldwidePEPperPRINT, RayBiotech, Creative-Biolabs, Aurora Innovation Inc Class A, Spectrum Solutions, Bio-Rad Laboratories Inc, BioNTech SE ADR, Merck KGaA, Innopsys


Other key industry trends

  • In terms of revenue, China accounted for 1.7% of the global peptide microarray market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan peptide microarray market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 24.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Peptide Microarray Market Scope

Peptide microarray market segmentation & scope
Instruments
Reagents
Services
Disease Diagnostics
Protein Functional Analysis
Antibody Characterization
Drug discovery
Pharmaceutical and Biotechnology Companies
Hospitals and Clinics
Diagnostic Centers
Others

Peptide Microarray Market Companies

Name Profile # Employees HQ Website

China peptide microarray market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peptide microarray market will help companies and investors design strategic landscapes.


Instruments was the largest segment with a revenue share of 53.28% in 2022. Horizon Databook has segmented the China peptide microarray market based on instruments, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to China peptide microarray market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China peptide microarray market databook

  • Our clientele includes a mix of peptide microarray market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China peptide microarray market, including forecasts for subscribers. This country databook contains high-level insights into China peptide microarray market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China peptide microarray market report size, by type, 2018-2030 (US$M)

China Peptide Microarray Market Share, 2022 & 2030 (US$M)

China peptide microarray market report size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more